*EISAI-E7080-J081-103

Study Sponsor: Eisai

Study Title

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Medicine or Vaccine (generic name)

lenvatinib

Sponsor Identification Number

E7080-J081-103

Trial Registry Identification Number(#'s)

NCT00280397

Medical Condition

Solid Tumors

Phase

Phase 1

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT00280397

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

Analysis and reporting datasets are not CDISC compliant and contain labelling in English and Japanese. Note: Japan is the only country participating in this study.

Date Added to this Site

September 2015